Weilong Zhang

10PUBLICATIONS
31CO-AUTHORS
Molecular targetsHaematological tumoursGenomics and transcriptomicsCancer diagnosisCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (10)

|Aug 27, 2026
CD73 inhibitor enhances the antitumor activity of selinexor in multiple myeloma by restoring the activation of CD8+ T cells.

|Jul 09, 2026
A Comprehensive Landscape of B Symptoms in Mantle Cell Lymphoma Reveals Heterogeneity Associated With Different Primary Sites.

|May 15, 2026
HESpotEx: a dual-stream deep learning framework for spot-level gene expression prediction from histological images.

|Mar 26, 2026
Current progress of CDC20 in cancer development and targeting CDC20 for cancer therapy.

Yingtong Chen, Shuang Gao, Ping Yang

|Mar 25, 2026
Targeting UHRF1 induces regression of aggressive mantle cell lymphoma.

Yuan Yang, Zengwei Tang, Qinglin Hu

|Mar 04, 2026
Cell-free chromatin state tracing reveals disease origin and therapy responses.

Xubin Chen, Xiaoxuan Meng, Weilong Zhang

Pageof 2

Frequent Collaborators

7 joint publications

Hongmei Jing

1 joint publications

Pei Wang

1 joint publications

Qianqian Song

1 joint publications

Jie Ren